Patient outcome studies are becoming increasingly important as they provide a truly in-depth analysis of the chosen subject matter as well as benefits to the participants.
We are pleased to announce that we will have a patient outcome study regarding melanoma very soon in the United States and the incentive will be up to $600. We are looking for oncologists and dermatologists practicing in the United States that specialize in melanoma treatments to participate in this exciting study.
This multi-stage study involves both treaters and those receiving the treatment providing an in-depth understanding of clinical, behavioral, and payer practice in distinct areas. All data is strictly confidential.
The data collected from this study will be used to ensure the best possible treatment guidelines. Furthermore, it will be published in peer-review journals and presented at key conferences.
If you are not a member and you wish to participate in this study, register below by clicking here.
If you are already a member of our panel and you wish to reserve your place, please let us know: M3_US_support@eu.m3.com
Read the interview with a melanoma specialist from the United States in the section “Our Doctors talk”.